Office-Based Diagnostic Procedures

  • Cassandra E. Chow
  • Frederick M. Dirbas


Visible or palpable breast abnormalities detected by the patient or a primary care provider are among the most common reasons for referral to a breast surgeon. During the initial consultation, a thorough history and clinical breast exam alone may provide significant insight into the patient’s problem, such as is the case with cyclical breast tenderness. Other complaints, such as nipple discharge or a palpable nodule, may be further investigated through a combination of straightforward, diagnostic office procedures. This chapter reviews several of these techniques.


False Negative Rate Core Biopsy Core Needle Biopsy Inflammatory Breast Cancer Invasive Lobular Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Pritt B, Pang Y, Kellogg M, et al. Diagnostic value of nipple cytology. Cancer. 2005; 102(4):233–8.CrossRefGoogle Scholar
  2. 2.
    Chaudary MA, Rosemary RM, Davies GC, et al. The diagnostic value of testing for occult blood. Ann Surg. 1982;196:651–5.PubMedCrossRefGoogle Scholar
  3. 3.
    Papinicolau GM, Holinquist DG, Bader GM, et al. Exfoliative cytology of the human mammary gland and its value in the diagnosis of cancer and other diseases of the breast. Cancer. 1958;11:377–409.CrossRefGoogle Scholar
  4. 4.
    Fischermann K, Bech I, Foged P, et al. Nipple discharge: diagnosis and treatment. Acta Chir Scand. 1969;135:403–6.PubMedGoogle Scholar
  5. 5.
    Schackmuth EM, Harlow CL, Norton LW. Milk fistula: a complication after core breast biopsy. AJR Am J Roentgenol. 1993;161:961–2.PubMedGoogle Scholar
  6. 6.
    Vetto J, Pommier R, Schmidt W, et al. Use of the “triple test” for palpable breast lesions yield high diagnostic accuracy and cost savings. Am J Surg. 1995;169:519–22.PubMedCrossRefGoogle Scholar
  7. 7.
    Morris A, Pommier RF, Schmidt WA, et al. Accurate evaluation of palpable breast masses by the triple test score. Arch Surg. 1998;133:930–4.PubMedCrossRefGoogle Scholar
  8. 8.
    Liberman L. Percutaneous image-guided core breast biopsy. Radiol Clin North Am. 2002; 40(3):483–500, vi.Google Scholar
  9. 9.
    Morrow M, Veta L, Stinson T, et al. Prospective comparison of stereotactic core biopsy and surgical excision as diagnostic procedures for breast cancer patients. Ann Surg. 2001;233: 537–41.PubMedCrossRefGoogle Scholar
  10. 10.
    Jackman RJ, Marzon FA, Finkelstein SI, et al. Benefits of diagnosing nonpalpable breast ­cancer with stereotactic large-core needle biopsy: lower costs and fewer operations. Radiology. 1996;201:311.Google Scholar
  11. 11.
    Burbank F. Mammographic findings after 14-gauge automated needle and 14-gauge directional, vacuum assisted stereotactic breast biopsies. Radiology. 1997;204:153–6.PubMedGoogle Scholar
  12. 12.
    Lamm RL, Jackman RJ. Mammographic abnormalities caused by percutaneous stereotactic biopsy of histologically benign lesions evident on follow-up mammograms. AJR Am J Roentgenol. 2000;174:753–6.PubMedGoogle Scholar
  13. 13.
    Liberman L, Dershaw D, Glassman JR, et al. Analysis of cancers not diagnosed at sterotactic core breast biopsy. Radiology. 1997;203:151–7.PubMedGoogle Scholar
  14. 14.
    Parker SH, Burbank F, Jackman RJ, et al. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology. 1994;193:359–64.PubMedGoogle Scholar
  15. 15.
    Brenner RJ, Fajardo L, Fisher PR, et al. Percutaneous core biopsy of the breast: effect of operator experience and number of samples on diagnostic accuracy. AJR Am J Roentgenol. 1996;166:341–6.PubMedGoogle Scholar
  16. 16.
    Liberman L. Clinical Management issues in percutaneous core breast biopsy. Radiol Clin of N Am. 2000;38(4):791–806.CrossRefGoogle Scholar
  17. 17.
    Rizzo M, Lund MJ, Oprea G, et al. Surgical followup and clinical persentatison of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy. Ann Surg Oncol. 2008;15(4):1040–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Dunn TM, Lucarotti ME, Wood SJ, et al. Exfoliative cytology in the diagnosis of breast ­disease. Br J Surg. 1995;82:789–91.PubMedCrossRefGoogle Scholar
  19. 19.
    Hatmaker AR, Donahue RM, Tarpley JL, Pearson AS. Cost-effective use of breast biopsy techniques in a Veterans health care system. Am J Surg. 2006;192(5):e37–41.PubMedCrossRefGoogle Scholar
  20. 20.
    Kaye MD, Vicinanza-Adami CA, Sullivan ML. Mammographic findings after sereotactic biopsy of the breast performed with large-core needles. Radiology. 1994;192:149–51.PubMedGoogle Scholar
  21. 21.
    Thompson M, Klimberg VS. Use of ultrasound in breast surgery. Surg Clin North Am. 2007;87(2):469–84.PubMedCrossRefGoogle Scholar
  22. 22.
    Morris KT, Pommier RF, Morris A, et al. Usefulness of the triple test score for palpable breast masses. Arch Surg. 2001;136:1008–13.PubMedCrossRefGoogle Scholar

Copyright information

© Springer New York 2010

Authors and Affiliations

  • Cassandra E. Chow
    • 1
  • Frederick M. Dirbas
  1. 1.Santa Clara Valley Medical CenterStanford University School of MedicineStanfordUSA

Personalised recommendations